Richard R. DeLuca Jr. - 23 Jan 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: EVP&Pres, Merck Animal Heallth
Signature: /s/ Kelly E. W. Grez as Attorney-in-Fact for Richard R. DeLuca, Jr.
Issuer symbol: MRK
Transactions as of: 23 Jan 2023
Net transactions value: +$1,717,205
Form type: 4
Filing time: 25 Jan 2023, 15:52:20 UTC
Previous filing: 01 Nov 2022
Next filing: 02 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRK	Common Stock	Award	$1,717,205	+15,628	+11%	$109.88	153,500	23 Jan 2023	Direct	F1, F2
holding	MRK	Common Stock - 401(k) Plan						1,198	23 Jan 2023	By 401(k)	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/20. Performance shares were paid out at 110 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2022.
F2	Holdings include shares acquired in dividend reinvestment transactions.
F3	Includes shares acquired and dividends earned through January 9, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.